Related Experiment Video
Updated: Jun 28, 2026

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts
Published on: November 5, 2012
ATRMec1 phosphorylation-independent activation of Chk1 in vivo
Yinhuai Chen1, Julie M Caldwell1, Elizabeth Pereira1
1Department of Pharmacology and Toxicology, Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, New Hampshire 03755 and Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0524.
Abstract:
The conserved protein kinase Chk1 is a player in the defense against DNA damage and replication blocks. The current model is that after DNA damage or replication blocks, ATR(Mec1) phosphorylates Chk1 on the non-catalytic C-terminal domain. However, the mechanism of activation of Chk1 and the function of the Chk1 C terminus in vivo remains largely unknown. In this study we used an in vivo assay to examine the role of the C terminus of Chk1 in the response to DNA damage and replication blocks. The conserved ATR(Mec1) phosphorylation sites were essential for the checkpoint response to DNA damage and replication blocks in vivo; that is, that mutation of the sites caused lethality when DNA replication was stalled by hydroxyurea. Despite this, loss of the ATR(Mec1) phosphorylation sites did not change the kinase activity of Chk1 in vitro. Furthermore, a single amino acid substitution at an invariant leucine in a conserved domain of the non-catalytic C terminus restored viability to cells expressing the ATR(Mec1) phosphorylation site-mutated protein and relieved the requirement of an upstream mediator for Chk1 activation. Our findings show that a single amino acid substitution in the C terminus, which could lead to an allosteric change in Chk1, allows it to bypass the requirement of the conserved ATR(Mec1) phosphorylation sites for checkpoint function.
Insights
The protein kinase Chk1 is vital for DNA damage response. A specific C-terminal mutation bypasses the need for ATR/Mec1 phosphorylation, enabling Chk1 checkpoint function.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- The protein kinase Chk1 is crucial for cellular defense against DNA damage and replication stress.
- Current models suggest ATR/Mec1 phosphorylates Chk1's C-terminal domain, but its activation mechanism and C-terminus function remain unclear.
Purpose of the Study:
- To investigate the role of the Chk1 C-terminus in DNA damage and replication block response in vivo.
- To elucidate the mechanism of Chk1 activation and the significance of ATR/Mec1 phosphorylation sites.
Main Methods:
- Utilized an in vivo assay to study Chk1 C-terminus function.
- Introduced mutations in ATR/Mec1 phosphorylation sites and specific C-terminal amino acids.
- Assessed cell viability and Chk1 kinase activity in vitro.
Main Results:
- ATR/Mec1 phosphorylation sites are essential for checkpoint response and cell viability during replication stress.
- Loss of these phosphorylation sites did not affect Chk1 kinase activity in vitro.
- A single amino acid substitution in the C-terminus restored viability and bypassed the need for ATR/Mec1 phosphorylation for Chk1 activation.
Conclusions:
- The Chk1 C-terminus plays a critical role in checkpoint activation.
- A specific C-terminal mutation can allosterically alter Chk1, bypassing the requirement for ATR/Mec1 phosphorylation sites for checkpoint function.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Restarting Stalled Replication Forks

